©2025 Stanford Medicine
Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
Not Recruiting
Trial ID: NCT05441696
Purpose
Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission
Official Title
Pilot Study for the Evaluation of EzCVP in Heart Failure Patients
Stanford Investigator(s)
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
Eligibility
Inclusion Criteria:
* Arm circumference of 23 cm to 55 cm
* Subject admitted to the hospital with acute exacerbation of heart failure, with either reduced or preserved ejection fraction
* Subject is at risk for readmission (NYHA Functional Classification 2-3)
* Subject is able to understand the risks and potential benefits of participating in the study and is willing to provide written, informed consent
* ezCVP indicator is high (CVPNI is over 9 mmHg) at admission
* Subject is willing and able to comply with protocol procedures
* Subject tested negative for COVID test after admission to the hospital
Exclusion Criteria:
* Finger and upper arm anatomical anomaly or disease that may interfere with attaching a pulse oximeter sensor and/or blood pressure cuff
* Pregnant (self-reported)
* Upper extremity DVT (currently being treated)
* Severe skin disease involving the upper arm(s)
* Study investigator may exclude patients based on clinical judgement
Intervention(s):
device: ezCVP measurement
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305